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Coenzyme Q (Q), an essential component of eukary-
otic cells, is synthesized by several enzymes from
the precursor 4-hydroxybenzoic acid. Mutations in
six of the Q biosynthesis genes cause diseases that
can sometimes be ameliorated by oral Q supplemen-
tation. We establish here that Coq6, a predicted
flavin-dependentmonooxygenase, is involved exclu-
sively in the C5-hydroxylation reaction. In an unusual
way, the ferredoxin Yah1 and the ferredoxin reduc-
tase Arh1 may be the in vivo source of electrons
for Coq6. We also show that hydroxylated analogs
of 4-hydroxybenzoic acid, such as vanillic acid or
3,4-dihydroxybenzoic acid, restore Q biosynthesis
and respiration in a Saccharomyces cerevisiae
coq6 mutant. Our results demonstrate that appro-
priate analogs of 4-hydroxybenzoic acid can bypass
a deficient Q biosynthetic enzyme and might be
considered for the treatment of some primary Q
deficiencies.
INTRODUCTION
Coenzyme Q or ubiquinone (Q) is a redox active lipid present in
most organisms and in all tissues of multicellular eukaryotes
where it shuttles electrons from complex I and II to complex III
of the mitochondrial respiratory chain and acts as an important
lipid-soluble antioxidant. Moreover, Q participates in the control
of the mitochondrial membrane transition pore and functions
with uncoupling proteins in the mitochondrial inner membrane
(Bentinger et al., 2010). Q contains a polyprenyl tail with six iso-
pentenyl units inSaccharomyces cerevisiae (Q6) and 10 in human
(Q10) (Kawamukai, 2009) (Figure 1). In S. cerevisiae, the biosyn-
thesis of Q is accomplished bymultiple conservedmitochondrial
matrix enzymes (termed Coq1-Coq9) some of which are assem-
bled in a large Q biosynthetic complex associated with the inner
membrane (Tran and Clarke, 2007). Mutations affecting five
genes involved in Q biosynthesis have been described and result1134 Chemistry & Biology 18, 1134–1142, September 23, 2011 ª201in primary Q deficiencies that cause clinically heterogeneous
diseases (Quinzii and Hirano, 2010). Oral Q10 supplementation
of patients yields significant improvement in some cases (Quinzii
and Hirano, 2010). Very recently, mutations in a sixth gene,
COQ6, were shown to cause nephrotic syndrome with sensori-
neural deafness (Heeringa et al., 2011).
The initial stage of Q biosynthesis involves Coq2. In
S. cerevisiae, Coq2 prenylates 4-hydroxybenzoic acid (4-HB)
or the newly identified precursor para-aminobenzoic acid
(pABA) to yield 3-hexaprenyl-4-hydroxybenzoic acid (HHB)
and 3-hexaprenyl-4-aminobenzoic acid (HAB), respectively
(Figure 1) (Marbois et al., 2010; Pierrel et al., 2010). TheC4-amine
originating from pABA is subsequently converted into an
hydroxyl at an unidentified step of Q6 biosynthesis (Figure 1).
S. cerevisiae cells depleted for either the mitochondrial ferre-
doxin Yah1 or the mitochondrial ferredoxin reductase Arh1
synthesize almost no Q6 and accumulate 3-hexaprenyl-4-
aminophenol (4-AP) upon culturing in the presence of pABA or
3-hexaprenyl-4-hydroxyphenol (4-HP) in the presence of 4-HB
(Figure 1) (Pierrel et al., 2010). This result established that Yah1
and Arh1 are absolutely required for the C5-hydroxylation step.
Arh1 and Yah1 form a well established electron transfer complex
necessary in S. cerevisiae for iron sulfur cluster (ISC) and heme
A biosynthesis (Barros et al., 2002; Lange et al., 2000; Li et al.,
2001). Yah1 has two human homologs, Fdx1 and Fdx2. Fdx1
functions in steroid biogenesis by transferring electrons to
mitochondrial cytochrome P450 enzymes whereas Fdx2 trans-
fers electrons for the biogenesis of heme A and ISC (Sheftel
et al., 2010).
Coq6 is required for Q6 biosynthesis in S. cerevisiae (Gin et al.,
2003) and, based on its amino acid sequence, has been pre-
dicted to belong to the class A flavoprotein monooxygenase
family suggesting that it contains a FAD cofactor (van Berkel
et al., 2006). Coq6 has been postulated to function in the C1-
and/or theC5-hydroxylation reactions (Gin et al., 2003) (Figure 1).
This ambiguity has not been resolved partly because a S. cerevi-
siae mutant lacking the entire COQ6 gene (Dcoq6) accumulates
only the early Q6 biosynthetic intermediate, HHB when grown in
the presence of 4-HB (Gin et al., 2003). In fact, the Dcoq3-9
mutants all accumulate HHB because most Coq polypeptides























































































Figure 1. Current Model of the S. cerevisiae Coenzyme Q Biosyn-
thetic Pathway
The names of proteins (underlined) and intermediates (italicized) relevant to
this study are for S. cerevisiae. The numbering of the aromatic carbon atoms
used throughout this study is shown on HHB and Q6. Prenylation of 4-hy-
droxybenzoic acid (4-HB) or para-aminobenzoic acid (pABA) by Coq2 yields
3-hexaprenyl-4-hydroxybenzoic acid (HHB) or 3-hexaprenyl-4-aminobenzoic
acid (HAB). In subsequent reactions, R stands for the hexaprenyl tail and
X designates NH2 or OH. NH2 is converted into OH prior to demethox-
yubiquinone (DMQ6) formation (Marbois et al., 2010; Pierrel et al., 2010). The
three hydroxylation reactions necessary to yield Q6 are shown in red and the
potential implication of Coq6 in the C5- and/or the C1-hydroxylation reactions
is indicated (Coq6?). In cells depleted for Yah1 or Arh1, the C5-hydroxylation is
deficient and results in synthesis of 3-hexaprenyl-4-aminophenol (4-AP) from
HAB and of 3-hexaprenyl-4-hydroxyphenol (4-HP) from HHB (green dashed
arrows and green boxes) (Pierrel et al., 2010).
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Chemistry & Biology 18, 1134–114for their stability within the Q biosynthetic complex (Hsieh et al.,
2007). Indeed, the absence of a single Coq polypeptide causes
the degradation of other Coq proteins (Tran and Clarke, 2007),
thus preventing the biosynthesis of Q6 intermediates diagnostic
of the altered step in Dcoq mutants. Consequently, it has been
difficult to elucidate the precise function of Coq4, Coq6, and
Coq9. Coq8, a predicted protein kinase, is essential for Q6
biosynthesis and participates in the phosphorylation of Coq3,
Coq5, and Coq7 (Tauche et al., 2008; Xie et al., 2011). Overex-
pression of Coq8 has been shown to restore the levels of Coq3
and Coq4 in most Dcoq mutants (Zampol et al., 2010). In addi-
tion, overexpression of Coq8 in a Dcoq7 strain causes the
accumulation of demethoxyquinone (DMQ6) (Padilla et al.,
2009), the substrate of the C6-hydroxylase, Coq7 (Stenmark
et al., 2001) (Figure 1). This result implies that overexpression
of Coq8 in the Dcoq7 strain prevents the degradation of the
Coq polypeptides involved in Q6 biosynthetic steps upstream
of Coq7. DMQ6 also forms in a Dcoq7 strain expressing the
inactive allele COQ7-E233K even in the absence of Coq8 over-
expression (Padilla et al., 2004). It therefore seems that single
mutations in a given Coq protein have less impact on the integrity
of the Q6 biosynthetic complex than null mutations.
In the current study, we sought to define which hydroxylation
step of Q6 biosynthesis is dependent on Coq6. We show that
a Dcoq6 strain expressing inactiveCOQ6 alleles or overexpress-
ing Coq8 accumulates products of the Q6 biosynthetic pathway
that establish that the monooxygenase Coq6 is specifically
required for the C5-hydroxylation reaction. The functional com-
bination of Yah1, Arh1, and Coq6 in the C5-hydroxylation reac-
tion is discussed. In addition, we demonstrate that hydroxylated
forms of 4-HB like vanillic acid or 3,4-dihydroxybenzoic acid are
able to restore Q6 biosynthesis and respiration in a S. cerevisiae
strain deficient for Coq6. This represents the first indication that
the use of 4-HB analogs might be considered as a strategy to
bypass defective steps in the Q biosynthetic pathway.
RESULTS
Coq6 Is Required for the C5- But Not
the C1-Hydroxylation Reaction of Q Biosynthesis
Regular synthetic yeast growth medium contains pABA that is
a precursor of Q6 (Marbois et al., 2010; Pierrel et al., 2010). In
order to control the nature of the precursors employed for Q6
biosynthesis, we used a synthetic medium without pABA for all
our experiments. Electrochemical detection (ECD) of cell lipid
extracts separated by HPLC revealed that addition of pABA or
4-HB to the growth medium increased the Q6 and DMQ6 content
of S. cerevisiae (see Figure S1A available online) consistent with
our previous conclusion that endogenous 4-HB is limiting for Q6
biosynthesis (Pierrel et al., 2010). Overexpression of Coq8 in the
Dcoq6 mutant strain led to an accumulation of 4-AP or 4-HP in
cells cultured in the presence of pABA or 4-HB, respectively,
whereas no products were formed in the absence of Coq8
overexpression (Figure 2A). Identities of 4-AP and 4-HP were
established previously (Pierrel et al., 2010) and here confirmed
by their retention time in HPLC chromatograms, their ultravi-
olet-visible spectra (Figure S1B) and the expected ion transitions
(m/z: 518.3/122 for 4-AP and 519.3/123 for 4-HP) in mass spec-
trometry coupled to HPLC (data not shown). Without pABA or2, September 23, 2011 ª2011 Elsevier Ltd All rights reserved 1135
Figure 2. Coq6 Is Required for the C5 but Not for the C1-Hydroxyl-
ation of Q6 Biosynthesis
(A) WT cells or Dcoq6 cells transformed with an empty vector (vec) or with an
episomal vector coding for Coq8 were grown in 2% glucose synthetic medium
withoutpABAcontainingornot100mM4-hydroxybenzoicacid (4-HB)or100mM
pABA. Lipid extracts of 1mg of cells (WT), 2mg of cells (/Coq8), or 8mg of cells
(/vec) were analyzed by HPLC-ECD. Chemical structures of 3-hexaprenyl-4-
aminophenol (4-AP, eluting at 610 s) and of 3-hexaprenyl-4-hydroxyphenol
(4-HP, eluting at 810 s) are displayed. The peaks corresponding to coenzyme
Q6 (Q6), demethoxyquinone (DMQ6), and to the Q4 standard are indicated.
(B) Dcoq6 cells transformed with an empty vector (vec) or centromeric vectors
coding either for Coq6 or Coq6-G386A-N388D were grown in glucose
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1136 Chemistry & Biology 18, 1134–1142, September 23, 2011 ª2014-HB supplementation of the growth medium, the Dcoq6 strain
overexpressing Coq8 accumulated 4-HP suggesting that
endogenous 4-HB enters the Q biosynthetic pathway preferen-
tially over endogenous pABA (Figure S1C). We also mutated
residues in Coq6 (G202, G386, N388) selected on the basis of
their conservation in other flavoprotein monooxygenases (Fig-
ure S2) in which they are implicated in the binding of NADPH
and FAD, as shown in the case of the parahydroxybenzoate
hydroxylase PobA (Eppink et al., 1997; Palfey et al., 1994). As
expected, a vector coding for Coq6 restored Q6 biosynthesis
in the Dcoq6 strain whereas G202A and G386A-N388D mutant
alleles of COQ6 were inactive as proven by the absence of Q6
and DMQ6 (Figure 2B; Figure S1C). However, these mutants
caused an accumulation of 4-AP in Dcoq6 cells cultured in the
presence of pABA, and of 4-HP upon growth in the presence
of 4-HB (Figure 2B). Together, these results show that a Dcoq6
strain either expressing a Coq6 protein inactivated by point
mutations or overexpressing Coq8 accumulates 4-AP and
4-HP. This finding demonstrates that the C1- but not the C5-
hydroxylation reaction is still catalyzed in the absence of Coq6
activity (Figure 1). Because Coq6 is a predicted FAD-dependent
monooxygenase (Gin et al., 2003; van Berkel et al., 2006), we
checked whether the C5-hydroxylation is dependent on the
availability of FAD in mitochondria. Deletion of the gene FLX1
that codes for a mitochondrial FAD transporter results in
decreased activity of FAD-dependent mitochondrial enzymes
(Bafunno et al., 2004; Tzagoloff et al., 1996). The Dflx1 strain
showed markedly diminished levels of Q6 and accumulated
4-AP and 4-HP when cultured in the presence of pABA and
4-HB respectively (Figure 2C). Furthermore, we observed that
overexpression of Fad1, the flavin adenine dinucleotide synthe-
tase, restored Q6 biosynthesis in the Dflx1 strain, however
without completely abolishing the formation of 4-HP (Figure 2C).
This result is in agreement with the overexpression of Fad1 being
able to partially complement themitochondrial FAD deficiency of
a flx1 mutant strain (Wu et al., 1995). Collectively, our results
show that the C5-hydroxylation depends on mitochondrial FAD
and that Coq6, a predicted FAD-dependent monooxygenase,
is essential for the C5- but not for the C1-hydroxylation reaction
of Q6 biosynthesis.
Vanillic Acid and 3,4-Dihydroxybenzoic Acid Restore
Q6 Biosynthesis in Strains Lacking Coq6 Activity
We tested whether hydroxylated forms of 4-HB like 3,4-dihy-
droxybenzoic acid (3,4-diHB) or vanillic acid (VA) (Figure S3A)
may enter the Q6 biosynthetic pathway and therefore bypass
the C5-hydroxylation step that is deficient in coq6 mutants.
Addition of 3,4-diHB or VA to the growth medium restored Q6
biosynthesis in a dose-dependent manner in the Dcoq6 strain
overexpressing Coq8 (Figure 3A; Figure S3B) or expressing the
inactive Coq6 mutant G386A-N388D (Figure S3C). The Dcoq6synthetic medium without pABA containing 100 mM pABA or 100 mM 4-HB.
Lipid extracts of 4 mg of cells were analyzed by HPLC-ECD.
(C) WT and Dflx1 cells transformed or not with an episomal vector coding for
Fad1 were grown in glucose synthetic mediumwithout pABA supplemented or
not with pABA or 4-HB at 100 mM. Lipid extracts of 4 mg of cells (Dflx1) and
1 mg of WT were analyzed by HPLC-ECD.
See also Figures S1 and S2.
1 Elsevier Ltd All rights reserved
Figure 3. Vanillic Acid and 3,4-Dihydroxybenzoic
Acid Restore Q6 Biosynthesis and Respiration in
coq6 Mutant Cells
(A) Dcoq6 cells transformed with an episomal vector
coding for Coq8 were grown in 2% glucose synthetic
medium without pABA containing the indicated concen-
trations of 4-HB, pABA, or vanillic acid (VA). Lipid extracts
of 4 mg of cells were analyzed by HPLC-ECD.
(B) Dcoq6 cells transformed either with an episomal
vector coding for Coq8, an empty vector (vec) or with
centromeric vectors coding forWTCoq6 or Coq6-G386A-
N388D were grown in glucose synthetic medium for 24 hr
and serial dilutions were spotted onto agar plates. The
plates contained synthetic medium without pABA sup-
plemented with 2% glucose (Glu) or 2% lactate-2%
glycerol (LG) and either vanillic acid (VA), pABA, or 3,4-
dihydroxybenzoic acid (3,4-diHB). The plates were incu-
bated for 2 days (Glu) or 4 days (LG) at 30C.
(C) Quantification of Q6 and 4-HP formed in Dcoq6 cells
overexpressing Coq8 grown in glucose synthetic medium
without pABA with 1mM VA and the indicated concen-
tration of 4-HB. Error bars are standard deviation (n = 2).
See also Figure S3.
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VA showing that the integrity of the Q biosynthetic complex is
required to convert VA in Q6 (Figure S3B). The Dcoq6 strain
overexpressing Coq8 or expressing Coq6-G386A-N388D was
able to grow on respiratory carbon sources supplemented with
3,4-diHB or VA, showing that Q6 biosynthesized from these
substrate analogs is physiologically functional (Figure 3B).
When pABA or 4-HB were added in place of VA or 3,4-diHB,
the cells were not able to grow on respiratory substrates
(Figure 3B), thus showing that 4-AP or 4-HP are not competent
for electron transfer in the respiratory chain. VA also restored
Q6 biosynthesis in the Dflx1 mutant to 70% of wild-type (WT)
(Figure S3D).
Addition of increasing concentrations of 4-HB to the growth
medium containing 1mM VA gradually decreased Q6 levels and
promoted the accumulation of 4-HP in the Dcoq6 strain overex-
pressing Coq8 (Figure 3C). pABA had a similar impact on Q6
levels at concentrations comparable to those of 4-HB (Fig-
ure S3E). Altogether our data show that exogenous pABA and
4-HB compete with VA to enter the Q6 biosynthetic pathway at
the prenylation step catalyzed by Coq2 and that prenylated
VA is converted into Q6, therefore bypassing the deficient C5-
hydroxylation reaction in coq6 mutant cells.
Coq6 and Yah1 Are Functionally Coupled
in the C5-Hydroxylation Reaction
Our results show that the phenotypes of cells depleted for Yah1
(Pierrel et al., 2010) or deficient for Coq6 are strikingly similar with
regard to Q6 biosynthesis suggesting a mechanism in which
Coq6 and Yah1 work together in the C5-hydroxylation step.
The following experiments establish indeed that depletion of
Yah1 directly impacts Coq6 activity. First, we demonstrate thatChemistry & Biology 18, 1134–1142, September 23,Coq6 is stable when Yah1 is depleted. We
constructed a Gal-YAH1 COQ6-3HA strain
that contains a chromosomal insertion of a
sequence coding for a triple hemagglutinin(3HA) epitope tag on the 30 end ofCOQ6 and allows for regulated
expression of Yah1. Indeed, the native YAH1 promoter has been
replaced by the GAL1-10 promoter allowing for expression of
Yah1 in a culture medium containing galactose and for depletion
of Yah1 in a medium containing glucose (Lange et al., 2000). The
Coq6-3HA protein was detected by immunoblotting at the ex-
pected size of 57 kDa (Figure 4A). Depletion of Yah1 by culturing
the Gal-YAH1 COQ6-3HA strain in the presence of glucose had
no effect on the steady-state level of Coq6 (Figure 4A). The pres-
ence of Coq6 in Yah1-depleted cells is also confirmed by the
observation that VA or 3,4-diHB restores Q6 biosynthesis in the
Yah1-depleted cells regardless of Coq8 overexpression (Fig-
ure S4A), thus showing that the Q biosynthetic complex is intact
and therefore that Coq6 is present. Second, overexpression of
Fad1 did not complement the Q6 biosynthetic defect in Yah1-
depleted cells (Figure S4B), suggesting that this defect does
not result from a depletion of mitochondrial FAD. These data
together show that Yah1 depletion, although having a negative
effect on Q6 biosynthesis, has no effect on Coq6 stability or
mitochondrial FAD content.
Human Fdx2 was recently shown to complement the ISC
biosynthetic defect of Yah1-depleted cells (Sheftel et al.,
2010). Surprisingly, none of the two human homologs of Yah1,
Fdx1, or Fdx2 complemented the Q6 defect of Yah1-depleted
cells as shown from the observation that the cells contained
almost no Q6 and furthermore accumulated 4-AP upon culture
in the presence of pABA (Figure 4B). Growth of the Gal-YAH1
strain on synthetic medium containing the respiratory carbon
source lactate was limited unless it contained a plasmid carrying
the YAH1 gene (Figure 4C). With a plasmid expressing Fdx2,
growth was restored upon addition of VA or 3,4-diHB to the
lactate mediumwhereas addition of 4-HB was without any effect2011 ª2011 Elsevier Ltd All rights reserved 1137
Figure 4. Q6 Is Limiting for Respiratory Growth of Yah1-Depleted Cells Expressing Fdx2
(A) Immunoblot of whole-cell lysates from WT, COQ6-3HA, and Gal-YAH1 COQ6-3HA (two clones) cells grown in YP rich medium containing either 2% glucose
(Glu) or 2% galactose (Gal). Coq6-3HA was detected at 57 kDa with an anti-HA antibody and as expected was absent from extracts of the WT strain. Yah1 was
detected around 16 kDa and Anc2, the major ADP/ATP carrier of the mitochondrial inner membrane, at 35 kDa.
(B) Gal-YAH1 cells transformed with an empty vector (vec), a centromeric vector coding for Yah1 or episomal vectors coding for mitochondrially targeted human
ferredoxin 1 or 2 (Fdx1 or Fdx2) were grown for 24 hr in synthetic medium supplemented with glucose and 1mM pABA. Lipid extracts of 4 mg of cells were
analyzed by HPLC-ECD.
(C) Same cells as in (B) were grown in glucose synthetic medium without pABA for 24 hr and serial dilutions were spotted onto agar plates. The plates contained
synthetic mediumwithout pABA supplemented at 2%with either glucose (Glu), galactose (Gal), or lactate (Lac) and either vanillic acid (VA), 3,4-dihydroxybenzoic
acid (3,4-diHB), or 4-HB. The plates were incubated for 4 days at 30C.
(D) Gal-YAH1 cells containing an empty vector (vec), a centromeric vector coding for Yah1 (Yah1) or an episomal vector coding for mitochondrially-targeted
human ferredoxin 2 (Fdx2) were cultivated in glucose syntheticmedium for 26 hr and finally in glucose syntheticmediumwithout pABA in the presence or absence
of 1 mM vanillic acid (VA) for 14 hr. Mitochondria were isolated and the enzyme activities of SDH (succinate to dichlorophenol-indophenol [DPIP]) and SDH in
combination with complex III (succinate to cytochrome c [cyt c]) were determined and normalized to malate dehydrogenase activity (MDH). Error bars are
standard deviation (n = 3).
See also Figure S4.
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3,4-diHB, Q6 is limiting for respiratory growth of the Gal-YAH1
strain expressing Fdx2. This was confirmed by measuring the
in vitro activity of succinate dehydrogenase (SDH), amultiprotein
complex that contains three ISC and one FAD, all required for
activity. As expected from the complementation of the ISC
biosynthetic defect of Yah1-depleted cells by Fdx2 (Sheftel
et al., 2010), Fdx2 significantly restored reduction of the chemi-
cal dichlorophenol-indophenol (DPIP) by SDH in Yah1-depleted
cells, although not to WT levels (Figure 4D). Q6 is required to
transfer electrons from SDH to the cytochrome bc1 complex
that reduces cytochrome c (cyt c). Fdx2 restored SDH-cyt c
reductase activity in Yah1-depleted cells only when VA was
added to the culture medium (Figure 4D). This result shows
that the limiting factor in transferring electrons from succinate
to cyt c in Yah1-depleted cells expressing human Fdx2 is Q6,
the level of which is restored by addition of VA to the growth
medium (Figure S4A).
DISCUSSION
Our current work addresses the precise functional role of the
Coq6 monooxygenase in the hydroxylation reactions of the Q1138 Chemistry & Biology 18, 1134–1142, September 23, 2011 ª201biosynthetic pathway. As shown previously in the case of the
Dcoq7 strain (Padilla et al., 2004, 2009), overexpression of
Coq8 or expression of inactive alleles of COQ6 allow for preser-
vation of the integrity of the Q6 biosynthetic complex in a Dcoq6
strain. We show here for the first time that under these condi-
tions, the Dcoq6 strain grown in the presence of pABA or 4-HB
accumulates significant amounts of 4-AP and 4-HP, respec-
tively. The accumulation of 4-AP and 4-HP is diagnostic of an
impaired C5-hydroxylation but of a functional C1-hydroxylation.
As a consequence, the predicted FAD-dependent monooxyge-
nase Coq6 is required for the C5-hydroxylation but not for
the C1-hydroxylation, definitively resolving the uncertainty
regarding which hydroxylation reaction is catalyzed by Coq6.
As a result, the C1-hydroxylase is still unknown (Figure 5) and
is unlikely to be any of the Coq proteins identified to date
because among these, only Coq6 and Coq7 display sequence
homologies with monooxygenases and Coq7 participates
exclusively in the C6-hydroxylation (Behan and Lippard, 2010;
Padilla et al., 2004). Some experiments reported here suggest
that the C1-hydroxylase is unlikely to be a FAD-dependent
monooxygenase. A Dflx1 strain, characterized by impaired
FAD-dependent mitochondrial activities (Bafunno et al., 2004;
Tzagoloff et al., 1996), accumulates 4-AP and 4-HP indicating1 Elsevier Ltd All rights reserved
Figure 5. Coq6 Is Required for the C5-Hydroxylation of Q6 Biosynthesis But Coq6 Deficiency Can Be Bypassed by Using Analogs of 4-HB
The pathway leading to Q6 biosynthesis in WT S. cerevisiae cells is shown (above dashed line) with Coq6 implicated together with Yah1 and Arh1 in the
C5-hydroxylation, whereas the C1-hydroxylation is catalyzed by an unidentified protein (?). In Yah1-depleted cells or in Dcoq6 cells overexpressing either COQ8
or an inactive COQ6 allele (below dashed line), the C5-hydroxylation does not take place (crossed arrow) but the C1-decarboxylation (dashed arrow) and the
C1-hydroxylation proceed efficiently, leading to the accumulation of 4-HP when 4-HB is prenylated, or the accumulation of 4-AP when pABA is prenylated (blue).
3,4-diHB and VA contain an additional C5-hydroxyl (green) or C5-methoxyl (green) compared to 4-HB. 3,4-diHB and VA that correspond to the unprenylated
products of the reactions catalyzed by Coq6 and Coq3 are prenylated in vivo by Coq2 and restore Q6 biosynthesis in cells deficient for Coq6.
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Furthermore, restoration of Q6 biosynthesis in Dflx1 strain by
VA (Figure S3D) is consistent with the C1-hydroxylation pro-
ceeding normally in the Dflx1 strain.
Our results show that VA and 3,4-diHB can be used as Q6
precursors and thus restore Q6 biosynthesis and respiration in
Dcoq6 cells overexpressing Coq8 or expressing the Coq6 inac-
tive alleles (Figure 5). This proves that analogs of 4-HB added to
the growth medium of S. cerevisiae can reach the mitochondrial
matrix, where Q6 biosynthesis takes place, and then enter the Q6
biosynthetic pathway via prenylation by Coq2 (Figure 5). The
strong impact of minor quantities of pABA or 4-HB observed
on the levels of Q6 synthesized from VA (Figure 3C and Fig-
ure S3E) may be explained by two nonexclusive hypotheses.
VA may not be as efficiently transported to the mitochondrial
matrix as pABA and 4-HB or Coq2 may have a higher affinity
for pABA and 4-HB compared to VA. In any case, Coq2 has
a broad substrate specificity in agreement with early in vitro
studies that showed that mitochondrial preparations from rat
heart and liver were able to prenylate VA and 3,4-diHB (Nambu-
diri et al., 1976). In fact, these analogs of 4-HB meet the struc-
tural requirements for prenylation by the polyprenyl transferase
Coq2, i.e., an electron-donating substituent at position 4 of the
aromatic ring combined with a carboxylic acid, a strong elec-
tron-attracting group, at position 1 (Alam et al., 1975). On the
contrary, 4-nitrobenzoic acid that harbors the strong electron-
attracting nitro group at position 4 inhibits Coq2 and as a conse-
quence acts as an inhibitor of Q biosynthesis in mammalian cells
cultures (Forsman et al., 2010). We would like to suggest that
4-HB analogs compatible with prenylation by Coq2 may also
bypass deficient Q biosynthetic steps downstream of the C5-
hydroxylation reaction. It is interesting to note that most muta-
tions identified so far in humans to cause primary Q deficiencyChemistry & Biology 18, 1134–114are not found in genes encoding enzymes that catalytically
modify the prenylated aromatic ring except for COQ6 (Heeringa
et al., 2011). In fact they are found in (1) PDSS1 and PDSS2
(Lopez et al., 2006; Mollet et al., 2007), which are the relatives
of COQ1 catalyzing the synthesis of the polyprenyl tail; (2) the
polyprenyl transferase COQ2 (Mollet et al., 2007); (3) ADCK3/
CABC1 (Lagier-Tourenne et al., 2008; Mollet et al., 2008), the
COQ8 homolog; and (4) COQ9, a gene with no specific function
assigned (Duncan et al., 2009). Our results suggest that VA may
be efficient at promoting Q10 biosynthesis in patients with COQ6
mutations. Practically, as vanillin (3-methoxy-4-hydroxybenzal-
dehyde), a common nontoxic food additive, is converted in the
liver to VA (Muskiet and Groen, 1979; Sayavongsaa et al.,
2007), vanillin may represent an interesting therapeutic molecule
to try in patients with COQ6 mutations.
Finally, we previously demonstrated that Yah1 and Arh1 are
essential for the C5-hydroxylation reaction (Pierrel et al., 2010).
The similar impact on Q6 biosynthesis of Yah1 or Arh1 depletion
or Coq6 inactivation raises the question of how these three
enzymes are functionally coupled. Here we provide preliminary
data aiming at understanding this link. Yah1/Arh1 form a ferre-
doxin/ferredoxin reductase system that transfers electrons for
different mitochondrial processes, in particular ISC assembly
(Lill, 2009). The fact that Fdx2, a human homolog of Yah1,
complements the ISC biosynthetic defect but not the Q6 biosyn-
thetic defect of Yah1-depleted cells excludes that Coq6 and thus
Q6 metabolism may indirectly be affected by an impairment of
ISC biosynthesis. Coq6 is classified among Class A flavoprotein
monooxygenases that have been described to contain a tightly
bound FAD cofactor and to depend on NAD(P)H as a coenzyme
for reduction of FAD (van Berkel et al., 2006). We checked
whether inactivation of Yah1 could indirectly cause a depletion
of mitochondrial NAD(P)H or FAD that would result in decreased2, September 23, 2011 ª2011 Elsevier Ltd All rights reserved 1139
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absence of Yah1, the Coq6 polypeptide is not degraded, mito-
chondrial FAD and NAD(P)H are available, and yet Coq6 is
unable to perform the C5-hydroxylation, implying that Yah1 itself
plays a role in this reaction. First, the Coq6-3HA polypeptide is
detected in Yah1-depleted cells. Second, a shortage of mito-
chondrial FAD, the predicted cofactor of Coq6, is unlikely.
Indeed, Yah1-depleted cells expressing Fdx2 are impaired for
the C5-hydroxylation reaction but display significant SDH
activity, known to depend on FAD. In addition, overexpression
of FAD1 restored Q6 biosynthesis in the Dflx1 strain whereas it
failed to do so in Yah1-depleted cells. Third, mitochondrial
NAD(P)H levels may not be dramatically affected in Yah1-
depleted cells expressing Fdx2 because the latter is able to
assemble ISC, a process supported by mitochondrial NADPH
(Pain et al., 2010). Also in support of this, Yah1-depleted cells
are prototroph for arginine (data not shown), the biosynthesis
of which requires mitochondrial NADPH produced by Pos5 via
phosphorylation of mitochondrial NADH (Outten and Culotta,
2003). As a conclusion, if Coq6 was a classical class A flavopro-
tein monooxygenase catalyzing reduction of FAD by NAD(P)H, it
should be active in Yah1-depleted cells because their levels
of mitochondrial FAD and NAD(P)H are not compromised.
Consequently, we end up with the hypothesis of an unusual
mechanism in which the reducing power of NAD(P)H may transit
via the Yah1/Arh1 system before reaching Coq6. The b-cyclo-
hexenyl carotenoid epoxidase, another class A flavoprotein
monooxygenase, has been shown to require a ferredoxin/
ferredoxin reductase system for in vitro activity (Bouvier et al.,
1996) and thus represents a precedent for such an electron
transfer pathway from a ferredoxin to a flavin-monoxygenase.
Unequivocal demonstration that Coq6 may also use an uncon-
ventional reducing system like Arh1/Yah1 will necessitate the
development of an in vitro assay with purified proteins; a
challenging task given that Coq6 likely interacts with several
Coq polypeptides in the Q6 biosynthetic complex (Marbois
et al., 2005). Nonetheless, our study has unambiguously estab-
lished that Coq6 is required exclusively for the C5-hydroxylation
of Q6 biosynthesis and that hydroxylated analogs of 4-HB can be
used as precursors of Q6, two results that significantly improve
our understanding of the biosynthesis of this crucial coenzyme.
SIGNIFICANCE
Coenzyme Q (Q) or ubiquinone, an important cellular antiox-
idant, is essential to electron transport chains and is re-
quired for several other cellular processes. Q biosynthesis
requires at least 11 proteins in S. cerevisiae but the precise
function of several of them is not known. Our work estab-
lishes that the predicted monoxygenase Coq6 is involved
in the C5-hydroxylation reaction and that an unidentified
monooxygenase catalyzes the C1-hydroxylation reaction.
We further demonstrate the possibility to bypass a deficient
Q biosynthetic step in S. cerevisiae by providing the defec-
tive chemical group within a synthetic 4-hydroxybenzoic
acid analog. Indeed, a coq6 mutant impaired in the C5-
hydroxylation reaction recovers Q6 biosynthesis and respi-
ration on addition of two such analogs, 3,4-dihydroxyben-
zoic acid and vanillic acid. Primary Q10 deficiencies have1140 Chemistry & Biology 18, 1134–1142, September 23, 2011 ª201been linked to mutations in six genes of the Q biosynthetic
pathway and result in clinically heterogeneous diseases
that, if diagnosed early, are improved by Q10 supplementa-
tion. However, the lipophilicity of Q10 may restrain its effi-
cient transport to the mitochondrial inner membrane where
Q10 functions in the respiratory chain (Quinzii and Hirano,
2010). Our work suggests that hydrophilic analogs of 4-hy-
droxybenzoic acid may restore Q10 biosynthesis in patients
with some primary Q10 deficiencies by bypassing the altered
biosynthetic step. The use of various 4-hydroxybenzoic acid
analogs will also contribute to characterize the biosynthetic
step(s) blocked in some S. cerevisiae coq mutants and will
thus help to identify the molecular function of Coq proteins
with unknown function. Our work illustrates the importance
of a molecular understanding of the Q biosynthetic pathway
and warrants the identification of yet unidentified proteins
that participates inQ biosynthesis, in particular themonoox-
ygenase responsible for the C1-hydroxylation reaction.
EXPERIMENTAL PROCEDURES
Yeast Strains and Culture Conditions
S. cerevisiae strains used in this study are listed in Table S1. S. cerevisiae
strains were transformed using lithium acetate. A 3HA epitope tag was in-
serted on the 30 end of COQ6 ORF by PCR as described previously (Longtine
et al., 1998) to create the COQ6-3HA strain. This strain was crossed with the
Gal-YAH1 strain to isolate the Gal-YAH1 COQ6-3HA strain by selecting the
corresponding markers after tetrad dissection. YNB without pABA and folate
was from MP Biomedicals. Rich YP medium was prepared as described
(Sherman, 2002). Glucose, galactose, or lactate-glycerol was used at 2%.
The Gal-YAH1 strain was maintained and precultured on galactose medium.
Depletion of Yah1 was accomplished by diluting 200-fold the preculture into
glucose containing medium and growing the cells for 18 hr at 30C.
Plasmids
COQ6 ORF was cloned into pRS416 under the control of theMET25 promoter
and the CYC1 terminator using XhoI and XbaI (Mumberg et al., 1994). This
vector served as a template to generate the G202V and G386A-N388D
Coq6 mutants by site directed mutagenesis. FAD1 was cloned with its own
promoter (370 bp) and terminator (210 bp) into pRS423 using EcoRI and
XhoI. Fdx1 and Fdx2 expressing plasmids have been described (Sheftel
et al., 2010) and COQ8 cloned in pFL44 was a kind gift from Dr. Genevie`ve
Dujardin. Sequencing was used to confirm cloning products in all created
vectors.
Miscellaneous Biochemical Analysis
Isolation of mitochondria and immunostaining were performed as described
(Diekert et al., 2001; Harlow and Lane, 1988). Cellular lipid extraction after
addition of the Q4 standard and quantification of electroactive compounds
by HPLC-ECD with a 5011A analytical cell (E1, –420 mV; E2, +380 mV)
were as described (Pierrel et al., 2010). Hydroquinones present in samples
were oxidized with a precolumn 5020 guard cell set in oxidizing mode
(E, +650 mV). Mitochondrial enzymatic activities were measured as previously
described (Pierik et al., 2009).
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and one table and can be
found with this article online at doi:10.1016/j.chembiol.2011.07.008.
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